drugset / Trial / NCT04672499
Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants
RandomizedSequentialDouble-blindTreatment
Summary
This study will assess the safety, tolerability, and pharmacokinetics (PK) of miricorilant (CORT118335) tablet formulations following single and multiple oral administration in healthy participants.
Timeline
- Start
- 2020-04-27
- Primary completion
- 2020-09-07
- Completion
- 2020-09-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Miricorilant | Small molecule | 300 mg | Oral |
| Subject | Miricorilant | Small molecule | 600 mg | Oral |
| Subject | Miricorilant | Small molecule | 750 mg | Oral |
| Subject | Miricorilant | Small molecule | 900 mg | Oral |
| Subject | Miricorilant | Small molecule | 1350 mg | Oral |
Indications
No indication recorded.